{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:00:37Z","timestamp":1788930037784,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA116477"],"award-info":[{"award-number":["R01 CA116477"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["13\/03876-4"],"award-info":[{"award-number":["13\/03876-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Dosimetry for diagnostic agents is performed to assess the risk of radiation detriment (e.g., cancer) associated with the imaging agent and the risk is assessed by computing the effective dose coefficient, <jats:italic>e<\/jats:italic>. Stylized phantoms created by the MIRD Committee and updated by work performed by Cristy-Eckerman (CE) have been the standard in diagnostic dosimetry. Recently, the ICRP developed voxelized phantoms, which are described in ICRP Publication 110. These voxelized phantoms are more realistic and detailed in describing human anatomy compared with the CE stylized phantoms. Ideally, all tissues should be represented and their pharmacokinetics collected for an as accurate a dosimetric calculation as possible. As the number of source tissues included increases, the calculated <jats:italic>e<\/jats:italic> becomes more accurate. There is, however, a trade-off between the number of source tissues considered, and the time and effort required to measure the time-activity curve for each tissue needed for the calculations. In this study, we used a previously published <jats:sup>68<\/jats:sup>Ga-DOTA-TATE data set to examine how the number of source tissues included for both the ICRP voxelized and CE stylized phantoms affected <jats:italic>e<\/jats:italic>.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Depending upon the number of source tissues included <jats:italic>e<\/jats:italic> varied between 14.0\u201323.5 \u03bcSv\/MBq for the ICRP voxelized and 12.4\u201327.7 \u03bcSv\/MBq for the CE stylized phantoms. Furthermore, stability in <jats:italic>e<\/jats:italic>, defined as a &lt; 10% difference between <jats:italic>e<\/jats:italic> obtained using all source tissues compared to one using fewer source tissues, was obtained after including 5 (36%) of the 14 source\u00a0tissues for the ICRP voxelized, and after including 3 (25%) of the 12 source\u00a0tissues for the CE stylized phantoms. In addition, a 2-fold increase in <jats:italic>e<\/jats:italic> was obtained when all source tissues where included in the calculation compared to when the TIAC distribution was lumped into a single reminder-of-body source term.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study shows the importance of including the larger tissues like the muscles and remainder-of-body in the dosimetric calculations. The range of <jats:italic>e<\/jats:italic> based on the included tissues were less for the ICRP voxelized phantoms using tissue weighting factors from ICRP Publication 103 compared to CE stylized phantoms using tissue weighting factors from ICRP Publication 60.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13550-020-0614-6","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:05:51Z","timestamp":1584576351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-2305","authenticated-orcid":false,"given":"Anders","family":"Josefsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaikangwol","family":"Siritantikorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Ranka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Willegaignon","family":"de Amorim de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Buchpiguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Tatit","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley E.","family":"Bolch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sgouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"issue":"3","key":"614_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2967\/jnumed.108.056036","volume":"50","author":"WE Bolch","year":"2009","unstructured":"Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature. J Nucl Med. 2009;50(3):477\u201384. https:\/\/doi.org\/10.2967\/jnumed.108.056036.","journal-title":"J Nucl Med."},{"key":"614_CR2","unstructured":"Loevinger R, Budinger T, Watson E. MIRD primer for absorbed dose calculations The society of nuclear medicine, New York, NY, USA. 1991:1-128."},{"key":"614_CR3","unstructured":"Cristy M, Eckerman K. Specific absorbed fractions of energy at various ages from internal photon sources. III. Five-year-old. ORNL\/TM-8381\/V3. 1987;3:1\u201342."},{"issue":"1-3","key":"614_CR4","first-page":"1","volume":"21","author":"ICRP","year":"1990","unstructured":"ICRP. ICRP publication 60. Recommendations of the international commission on radiological protection. Ann ICRP. 1990;21(1-3):1\u2013227.","journal-title":"Ann ICRP"},{"issue":"2","key":"614_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.icrp.2009.07.001","volume":"39","author":"ICRP","year":"2009","unstructured":"ICRP (2009) ICRP publication 110. Realistic reference phantoms: an ICRP\/ICRU joint effort. A report of adult reference computational phantoms. Ann ICRP 39(2):1\u2013164 https:\/\/doi.org\/10.1016\/j.icrp.2009.09.001, https:\/\/doi.org\/10.1016\/j.icrp.2011.08.009.","journal-title":"Ann ICRP"},{"issue":"2","key":"614_CR6","first-page":"1","volume":"45","author":"ICRP","year":"2016","unstructured":"ICRP. ICRP Publication 133. The ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions. Ann ICRP. 2016;45(2):1\u201374.","journal-title":"Ann ICRP"},{"issue":"2-4","key":"614_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.icrp.2007.11.001","volume":"37","author":"ICRP","year":"2007","unstructured":"ICRP. ICRP publication 103. Recommendations of the international commission on radiological protection. Ann ICRP. 2007;37(2-4):1\u2013332.","journal-title":"Ann ICRP"},{"issue":"8","key":"614_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2967\/jnumed.117.203893","volume":"59","author":"A Josefsson","year":"2018","unstructured":"Josefsson A, Hobbs RF, Ranka S, Schwarz BC, Plyku D, Willegaignon de Amorim de Carvalho J, et al. Comparative Dosimetry for (68)Ga-DOTATATE: Impact of Using Updated ICRP Phantoms, S Values, and Tissue-Weighting Factors. J Nucl Med. 2018;59(8):1281\u20138. https:\/\/doi.org\/10.2967\/jnumed.117.203893.","journal-title":"J Nucl Med."},{"issue":"7","key":"614_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2967\/jnumed.116.179366","volume":"58","author":"D Plyku","year":"2017","unstructured":"Plyku D, Hobbs RF, Huang K, Atkins F, Garcia C, Sgouros G, et al. Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET\/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. J Nucl Med. 2017;58(7):1146\u201354. https:\/\/doi.org\/10.2967\/jnumed.116.179366.","journal-title":"J Nucl Med."},{"issue":"3","key":"614_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.icrp.2008.10.006","volume":"38","author":"ICRP","year":"2008","unstructured":"ICRP. ICRP publication 107. Nuclear decay data for dosimetric calculations. Ann ICRP. 2008;38(3):1\u201396.","journal-title":"Ann ICRP"},{"issue":"6","key":"614_CR11","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46(6):1023\u20137.","journal-title":"J Nucl Med."},{"issue":"3","key":"614_CR12","first-page":"1","volume":"32","author":"ICRP","year":"2002","unstructured":"ICRP. ICRP publication 89. Basic anatomical and physiological data for use in radiological protection: reference values. Ann ICRP. 2002;32(3):1\u2013277.","journal-title":"Ann ICRP"},{"issue":"6","key":"614_CR13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2967\/jnumed.112.114165","volume":"54","author":"RC Walker","year":"2013","unstructured":"Walker RC, Smith GT, Liu E, Moore B, Clanton J, Stabin M. Measured human dosimetry of 68Ga-DOTATATE. J Nucl Med. 2013;54(6):855\u201360.","journal-title":"J Nucl Med."},{"issue":"10","key":"614_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2967\/jnumed.113.120600","volume":"54","author":"M Sandstr\u00f6m","year":"2013","unstructured":"Sandstr\u00f6m M, Velikyan I, Garske-Rom\u00e1n U, S\u00f6rensen J, Eriksson B, Granberg D, et al. Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors. J Nucl Med. 2013;54(10):1755\u20139.","journal-title":"J Nucl Med."},{"issue":"11","key":"614_CR15","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","volume":"58","author":"L Bodei","year":"2017","unstructured":"Bodei L, Ambrosini V, Herrmann K, Modlin I. Current concepts in (68)Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies. J Nucl Med. 2017;58(11):1718\u201326. https:\/\/doi.org\/10.2967\/jnumed.116.186361.","journal-title":"J Nucl Med."},{"issue":"2","key":"614_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00411-009-0260-x","volume":"49","author":"W Bolch","year":"2010","unstructured":"Bolch W, Lee C, Wayson M, Johnson P. Hybrid computational phantoms for medical dose reconstruction. Radiation and Environmental Biophysics. 2010;49(2):155\u201368. https:\/\/doi.org\/10.1007\/s00411-009-0260-x.","journal-title":"Radiation and Environmental Biophysics."},{"issue":"2","key":"614_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1088\/0031-9155\/55\/2\/002","volume":"55","author":"C Lee","year":"2010","unstructured":"Lee C, Lodwick D, Hurtado J, Pafundi D, Williams JL, Bolch WE. The UF family of reference hybrid phantoms for computational radiation dosimetry. Phys Med Biol. 2010;55(2):339\u201363. https:\/\/doi.org\/10.1088\/0031-9155\/55\/2\/002.","journal-title":"Phys Med Biol."}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-0614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-020-0614-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-0614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:34:20Z","timestamp":1616114060000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-0614-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-0614-6","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.The institutional review board at S\u00e3o Paulo University School of Medicine, S\u00e3o Paulo SP, Brazil, approved this study and all subjects signed written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. George Sgouros is the founder and holds equity in Radiopharmaceutical Imaging and Dosimetry, LLC, a Johns Hopkins startup, conflicts of interest are managed according to Johns Hopkins Office of Policy Coordination. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}